CROS NT Biostatisticians Co-Author Moderate Asthma Study Results in The Lancet Medical Journal

CROS NT’s Chairman, Paolo Morelli, and biostatistician, Marco Pannacci, are co-authors on a recent paper published in the The Lancet Respiratory Medicine featuring the results of a moderate asthma clinical trial sponsored by the Italian Medicines Agency (AIFA). The full article can be found at http://www.thelancet.com/journal/lanres/issue/current in the Lancet’s most recent issue. Paolo Morelli, given…